Core Viewpoint - Company reported a mixed performance in Q4 2024, with revenue growth but declining net profit, highlighting challenges in the competitive landscape of the electronic chemicals industry [1][2][3] Financial Performance - For the year 2024, company achieved revenue of 1.099 billion yuan (YoY +7%) and net profit of 99 million yuan (YoY -6%) [1] - In Q4 2024, revenue was 279 million yuan (YoY +8%, QoQ -7%), with net profit of 12 million yuan (YoY +84%, QoQ -58%) [1] - Gross margin for Q4 2024 was 23.68%, with a year-over-year increase of 1.12 percentage points but a quarter-over-quarter decrease of 1.67 percentage points [1] Product Performance - Company sold 103,800 tons of ultra-pure reagents in 2024 (YoY +0.43%), generating revenue of 688 million yuan (YoY +3.33%) [2] - Sales of photoresist supporting reagents reached 34,600 tons (YoY +4.49%), with revenue of 381 million yuan (YoY +15.90%) [2] - In Q4 2024, ultra-pure reagent sales were 26,200 tons (QoQ +0.44%), with revenue of 175 million yuan (QoQ -4.26%) [2] Capacity Utilization and Strategic Focus - Company is enhancing competitive advantages through three main production bases, with Jiangyin base achieving a capacity utilization rate of 96.88% [3] - The Zhenjiang base is a key focus for future operations, with ongoing construction of the second phase project [3] - In the semiconductor sector, company generated revenue of 583 million yuan in 2024 (YoY +16.8%) [3] Market Outlook and Projections - Despite competitive pressures, company anticipates a stable pricing environment for high-end products, projecting a 20% sales growth for ultra-pure reagents and photoresist supporting reagents from 2025 to 2027 [4] - Adjusted net profit forecasts for 2025 and 2026 are 120 million yuan and 164 million yuan, respectively, with a new projection of 218 million yuan for 2027 [4]
江化微(603078):Q4业绩环比承压 期待镇江高端产能在半导体领域持续放量